• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    The biggest obstacle to congressional approval of TPP appears to be the deal's inadequate protection of intellectual property in
    Healthcare

    TPP trade agreement undercuts biologic patents

    John Graham -
    December 15, 2015 5:01 am
    0
    During the first Senate hearing on high drug prices last week, senators from both parties lauded a solution that would speed approval of certain generic drugs. (AP Photo)
    Healthcare

    Would speeding drug approvals knock down high prices?

    Robert King -
    December 15, 2015 5:01 am
    0
    Healthcare

    Congress may take on high drug prices next year

    Robert King -
    December 10, 2015 12:10 am
    0
    Healthcare

    GOP defends industry at drug price hearing

    Robert King -
    December 9, 2015 9:40 pm
    0
    Local governments need naloxone as an antidote to heroin overdoses, but the price is soaring. (AP Photo/Mel Evans)
    Healthcare

    High drug prices collide with efforts to stop overdoses

    Robert King -
    December 9, 2015 5:01 am
    0
    Healthcare

    Partisan attacks mark Dem drug price hearing

    Robert King -
    December 3, 2015 5:01 am
    0
    In a new analysis, Kaiser and Georgetown University looked at 12 specialty drugs used to treat four diseases: cancer, hepatitis C, multiple sclerosis and rheumatoid arthritis. (AP Photo/Rafiq Maqbool)
    Healthcare

    Seniors face high costs for pricey drugs

    Robert King -
    December 2, 2015 6:20 pm
    0
    The drugs Harvoni and Sovaldi, made by Gilead, threw Medicare for a loop when they hit the market.
    Healthcare

    Drug maker not concerned with ‘headlines’ on pricey drug

    Robert King -
    December 2, 2015 5:01 am
    0
    Turing Pharmaceuticals and its CEO Martin Shkreli created a massive public backlash earlier this fall when the company hiked the price of Daraprim from $13.50 to $750 a pill. (AP Photo/Craig Ruttle)
    Healthcare

    Pharma company cuts drug price after public backlash

    Robert King -
    November 25, 2015 3:46 pm
    0
    Pfizer executives donated $39,375 directly to Clinton's presidential campaign between April and the end of September, according to Federal Election Commission records. (AP Photo/Charlie Neibergall)
    Healthcare

    Clinton blasts Pfizer, a major Clinton donor

    Sarah Bedford -
    November 23, 2015 8:55 pm
    0
    1...132133134...158Page 133 of 158
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.